In conclusion, This study clarified the biological functions and mechanisms of C2orf40, as a tumor suppressor gene, in NPC, and provided a potential molecular target for improving the sensitivity of NPC cells to radiotherapy and chemotherapy. This evidence concerns the gene ECRG4 and nasopharyngeal carcinoma.